Characterization of a thrombin cleavage site mutation (Arg 1689 to Cys) in the factor VIII gene of two unrelated patients with cross-reacting material-positive hemophilia A.
暂无分享,去创建一个
S. Antonarakis | M. Higuchi | H. Kazazian | J. Phillips | R. Janco | L. Hoyer | M. Arai
[1] S. Antonarakis,et al. Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine). , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[2] E. Tuddenham,et al. Purification and characterization of factor VIII 1,689-Cys: a nonfunctional cofactor occurring in a patient with severe hemophilia A. , 1989, Blood.
[3] B. Levinson,et al. Mutations of factor VIII cleavage sites in hemophilia A. , 1988, Blood.
[4] S. Antonarakis,et al. The molecular basis of hemophilia A in man. , 1988, Trends in genetics : TIG.
[5] R. Kaufman,et al. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Antonarakis,et al. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man , 1988, Nature.
[7] W. Kane,et al. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. , 1988, Blood.
[8] S. Antonarakis,et al. Characterization of five partial deletions of the factor VIII gene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Antonarakis,et al. Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots , 1986, Nature.
[10] G. Vehar,et al. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. , 1986, Biochemistry.
[11] S. Antonarakis,et al. Hemophilia A. Detection of molecular defects and of carriers by DNA analysis. , 1985, The New England journal of medicine.
[12] L. Holland,et al. Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopes. , 1985, The Journal of clinical investigation.
[13] J. Roberts,et al. Thrombin proteolysis of purified factor viii procoagulant protein: correlation of activation with generation of a specific polypeptide. , 1983, Blood.
[14] E. Tuddenham,et al. Immunologic studies of factor VIII coagulant activity (VIII:C) 1. Assays based on a haemophilic and an acquired antibody to VIII:C. , 1981, Thrombosis research.
[15] J. Lavergne,et al. Immunoradiometric Assay of Factor VIII: Coagulant Antigen using Four Human Antibodies. Study of 27 Cases of Haemophilia A , 1981, British journal of haematology.
[16] H. Reisner,et al. Factor VIII coagulant antigen in hemophilic plasma: a comparison of five alloantibodies. , 1980, Blood.
[17] L. Hoyer,et al. Immunoradiometric measurement of the factor VIII procoagulant antigen. , 1978, The Journal of clinical investigation.
[18] L. Hoyer. Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen. , 1972, The Journal of laboratory and clinical medicine.
[19] L. Hoyer,et al. Immunologic studies of antihemophilic factor (AHF, factor VIII): cross-reacting material in a genetic variant of hemophilia A. , 1968, Blood.
[20] Henry A. Erlich,et al. Characterization of β-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA , 1987, Nature.
[21] E. Chen,et al. Detection and sequence of mutations in the factor VIII gene of haemophiliacs , 1985, Nature.
[22] L. Hoyer,et al. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation. , 1981, The Journal of laboratory and clinical medicine.